CA088-1005
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Arms / Cohorts
Experimental, Arm C:Part 1: BMS-986393 + Iberdomide
Accepting patients
Experimental, Arm C:Part 2: BMS-986393 + Iberdomide
Not yet accepting
Experimental, Arm B:Part 1: BMS-986393 + Mezigdomide
Accepting patients
Experimental, Arm B:Part 2: BMS-986393 + Mezigdomide
Not yet accepting
Experimental, Arm D:Part 2: BMS-986393 + Elranatamab
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.